KIMSOTUS

Focus on #inspiration #motivation Due diligence is a must. Opinion only, not any financial advice. Good luck!

[KIMSOTUS @kimsotus_]

@peralfredsson1 Steady onward! Rooting for T2 across the pond! 🙏🤙

[KIMSOTUS @kimsotus_]

@ChengKeki FEMY didn't have shares available to short, which meant the only selling was from folks taking profits that they paid into. It was a positive forward momentum without the deleterious undercutting of shortsales.

[KIMSOTUS @kimsotus_]

$TTOO The clearance of the T2 BioThreat panel

[KIMSOTUS @kimsotus_]

$TTOO The holy grail of sepsis diagnostics:
✅Bacterial detection (T2Bacteria)
✅Fungal detection (T2Candida)
📥Antibiotic Resistance Markers (T2Resistance, Currently testing)

[Doubting Thomas 🇺🇸 @ryanthomas88882]

@Jay93231852 $ttoo

Not only did the government fund @T2Bio bio threat development, they are also pushing for sepsis protection and identification innovations. 👍

[KIMSOTUS @kimsotus_]

@cheklis3 That language is the perfect strong-arm against the decades old "blood culture" method. 😇

[KIMSOTUS @kimsotus_]

$TTOO FDA clearance for T2Biothreat hasn't been SEC filed, Does anyone think we might get a 2nd Chance FDA Clearance BULL RUN once it hits the SEC filing? 😎🤙

[KIMSOTUS @kimsotus_]

@ChengKeki @BullLogic @TaylorTrader923 It was more like, soon after they got the SEC Notice of Effectiveness (Sept 15, 2023 4:30 P.M.), which is when the SEC recognizes the shares to be offered as tradable securities, that they decided to sell the stock. The timing of FDA approval was absolute coincidence.

[KIMSOTUS @kimsotus_]

@T7EJY @TaylorTrader923 Love the respectful words. Love your etiquette. Special thanks for that read.

[KIMSOTUS @kimsotus_]

$TTOO The BreakThrough Device designation of the Candida Auris panel--that is to be added to the already cleared Candida panel--will usher in an Equivalence precedent for 510(k) clearance of another panel in testing. See the big picture? 😇(Hint: AMR)
https://t.co/SbdkStCwE6

[KIMSOTUS @kimsotus_]

@r3a1ist1 @WormDirt6 $TTOO The addition of Candida auris detection to the already cleared Candida panel will usher in an important device equivalence for T2. The T2Resistance panel will soon follow. This will be huge.

[KIMSOTUS @kimsotus_]

@fgbullard2 Blood culture has low sensitivity, approx 60% which increases chances of missing a positive detection. "Those platforms (re: competitors) are only as good as their clinical specimen and blood culture itself is a poor clinical specimen by most standards"

https://t.co/0hN5tSgMn4

[KIMSOTUS @kimsotus_]

@BarkingSpidey $TTOO Does that represent the entirety of the "dilution" that FUD's have been yapping about? That .40 to .32 price range impact of that entire liquidation for that day. We still sit strong at present then.

[KIMSOTUS @kimsotus_]

@TinMan4U2 @BarkingSpidey $TTOO Rooting for T2 to remain steadfast. With FDA-cleared BioThreat panel, it is a powerful tool for society in rapid diagnostics of disease-causing bio-pathogens in both humans and animals (i.e. livestock, horses, etc). 💪🤙

[KIMSOTUS @kimsotus_]

@t2ttootrain $TTOO BARDA contract has 3 products that are listed as the development goals: BioThreat panel-(FDA CLEARED), Expanded Bacteria panel, and the Next-Gen Instrument. https://t.co/MiHlzQhVQa

[KIMSOTUS @kimsotus_]

@MargieLynFuller $TTOO My guess is now that BioThreat panel is completed & FDA CLEARED, they can focus on the next items of the Expanded Bacteria panel and/or the Next-Gen Instrument. 👍👍 https://t.co/MiHlzQhVQa

[KIMSOTUS @kimsotus_]

@Biotekster @MargieLynFuller $TTOO BARDA contract has 3 products that are listed as the development goals: BioThreat panel, Expanded Bacteria panel, and the Next-Gen Instrument. https://t.co/MiHlzQhVQa

[KIMSOTUS @kimsotus_]

@BenedettoAlchi1 "I think what's considered the holy grail of dealing with sepsis diagnostics is a comprehensive sepsis panel that combines bacterial detection, fungal detection, and resistance markers in one test, and we're making outstanding progress on that."-Sperzel, NewYorkBIO, 9/21/2021

[KIMSOTUS @kimsotus_]

$TTOO It's our time. T2 LEAD THE WAY!

[KIMSOTUS @kimsotus_]

$TTOO Confirmed. Date Received 05/08/2023 Decision Date09/15/2023 Decision SUBSTANTIALLY EQUIVALENT (SESE)

TO THE MOON!